We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4817 | -15.6818699743 | 3.0717 | 3.4 | 2.23 | 224386 | 2.72856993 | CS |
4 | 0.87 | 50.5813953488 | 1.72 | 5.5 | 1.5 | 1069802 | 3.79964766 | CS |
12 | -1.41 | -35.25 | 4 | 5.5 | 1.42 | 576440 | 3.73035571 | CS |
26 | -1.41 | -35.25 | 4 | 5.5 | 1.42 | 576440 | 3.73035571 | CS |
52 | -1.41 | -35.25 | 4 | 5.5 | 1.42 | 576440 | 3.73035571 | CS |
156 | -1.41 | -35.25 | 4 | 5.5 | 1.42 | 576440 | 3.73035571 | CS |
260 | -1.41 | -35.25 | 4 | 5.5 | 1.42 | 576440 | 3.73035571 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions